Anticorps Monoclonal anti-MYPT1
MYPT1 Monoclonal Antibody for IF, WB, ELISA
Hôte / Isotype
Mouse / IgG3
Réactivité testée
Humain, rat, souris
Applications
WB, IF, ELISA
Conjugaison
Non conjugué
CloneNo.
2A1A9
N° de cat : 66506-1-Ig
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules Raji, cellules HEK-293, cellules HeLa, cellules Jurkat, cellules K-562 |
Résultats positifs en IF | cellules HeLa, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:2000-1:12000 |
Immunofluorescence (IF) | IF : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
WB | See 1 publications below |
Informations sur le produit
66506-1-Ig cible MYPT1 dans les applications de WB, IF, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Réactivité citée | rat |
Hôte / Isotype | Mouse / IgG3 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | MYPT1 Protéine recombinante Ag17496 |
Nom complet | protein phosphatase 1, regulatory (inhibitor) subunit 12A |
Masse moléculaire calculée | 1030 aa, 115 kDa |
Poids moléculaire observé | 115 kDa |
Numéro d’acquisition GenBank | BC111752 |
Symbole du gène | PPP1R12A |
Identification du gène (NCBI) | 4659 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine A |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Myosin phosphatase target subunit 1(MYPT1), which is also called PPP1R12A, is one of the subunits of myosin phosphatase. Myosin phosphatase regulates the interaction of actin and myosin downstream of the guanosine triphosphatase Rho. The small guanosine triphosphatase Rho is implicated in myosin light chain (MLC) phosphorylation, which results in contraction of smooth muscle and interaction of actin and myosin in nonmuscle cells. The guanosine triphosphate (GTP)-bound, active form of RhoA (GTP.RhoA) specifically interacted with the myosin-binding subunit (MBS) of myosin phosphatase, which regulates the extent of phosphorylation of MLC. Rho-associated kinase (Rho-kinase), which is activated by GTP. RhoA, phosphorylated MBS and consequently inactivated myosin phosphatase. Overexpression of RhoA or activated RhoA in NIH 3T3 cells increased phosphorylation of MBS and MLC. Thus, Rho appears to inhibit myosin phosphatase through the action of Rho-kinase. Phosphorylation of MYPT1 at Thr696 and Thr853 results in phosphatase inhibition and cytoskeletal reorganization.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for MYPT1 antibody 66506-1-Ig | Download protocol |
IF protocol for MYPT1 antibody 66506-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Brain Res The ROCK inhibitor Y-27632 ameliorates blood-spinal cord barrier disruption by reducing tight junction protein degradation via the MYPT1-MLC2 pathway after spinal cord injury in rats. |